Detalhe da pesquisa
1.
Effect of Anti-Iduronate 2-Sulfatase Antibodies in Patients with Mucopolysaccharidosis Type II Treated with Enzyme Replacement Therapy.
J Pediatr
; 248: 100-107.e3, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568060
2.
Can serial cerebral MRIs predict the neuronopathic phenotype of MPS II?
J Inherit Metab Dis
; 44(3): 751-762, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33330992
3.
Genotype-phenotype relationship in mucopolysaccharidosis II: predictive power of IDS variants for the neuronopathic phenotype.
Dev Med Child Neurol
; 59(10): 1063-1070, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28543354
4.
Up to five years experience with 11 mucopolysaccharidosis type VI patients.
Mol Genet Metab
; 109(1): 70-6, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23523338
5.
Treatment options for lysosomal storage disorders: developing insights.
Expert Opin Pharmacother
; 13(16): 2281-99, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23009070